ESC 365 - Strategies treating for newly diagnosed heart failure patients – guideline directed medical therapy, the WCD, and time.

EHRA Premium Access

Strategies treating for newly diagnosed heart failure patients – guideline directed medical therapy, the WCD, and time.

Session: Proven protection from sudden cardiac death – The wearable cardioverter defibrillator

Topic: Ventricular Arrhythmias and SCD - Prevention

Speaker: Professor D. Scherr (Graz, AT)

Sponsored by Zoll CMS GmbH

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Professor Daniel Scherr

Medical University of Graz, Graz (Austria)

19 presentations

3 followers

4 more presentations in this session

Introduction - Proven protection from sudden cardiac deatch - The wearable cardioverter defibrillator.

Speaker: Doctor O. Piot (Saint Denis, FR)

Primary Prevention with the WCD: Vest Prevention of Early Sudden Cardiac Death (VEST) Trial

Speaker: Doctor J. Olgin (San Francisco, US)

WEARIT-II Europe: data from a German multi-center prospective registry.

Speaker: Professor C. Veltmann (Bremen, DE)

Panel discussion and summary.

Speaker: Professor H. Burri (Geneva, CH)

Access the full session

Proven protection from sudden cardiac death – The wearable cardioverter defibrillator

Speakers: Professor D. Scherr, Doctor O. Piot, Doctor J. Olgin, Professor C. Veltmann, Professor H. Burri

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources